BeStock  
Stocks › Diagnostics & Research › MEDP

Medpace MEDP

US equityMarket cap rank #631Diagnostics & Research
$611.90 −$12.28 (-1.97%)
Market open · Oct 1, 11:50 am ET · After hours $624.18 0.00%
Open$626.88
Prev close$624.18
Day range$611.04 – $628.04
Volume50.1K
Market cap$17.08B
P/E (TTM)36.0
Dividend yield–

MEDP Stock News

Headlines matching Medpace or the MEDP ticker, most recent first.

  • UBS Initiates Medpace(MEDP.US) With Hold Rating, Announces Target Price $673Market news · 30 Sep 2026
  • Medpace(MEDP.US) 10% Shareholder Sells US$44.43 Million in Common StockMarket news · 24 Sep 2026
  • Medpace(MEDP.US) 10% Shareholder Sells US$6.75 Million in Common StockMarket news · 22 Sep 2026
  • Medpace(MEDP.US) 10% Shareholder Sells US$15.36 Million in Common StockMarket news · 18 Sep 2026
  • Truist Financial Maintains Medpace(MEDP.US) With Hold RatingMarket news · 17 Sep 2026
  • Baird Downgrades Medpace(MEDP.US) to Hold Rating, Raises Target Price to $547Market news · 8 Jul 2026
  • Mizuho Securities Maintains Medpace(MEDP.US) With Buy Rating, Maintains Target Price $665Market news · 29 Jul 2026
  • Truist Financial Maintains Medpace(MEDP.US) With Hold Rating, Maintains Target Price $609Market news · 29 Jul 2026
  • Mizuho Securities Maintains Medpace(MEDP.US) With Buy Rating, Raises Target Price to $665Market news · 25 Jul 2026
  • A Quick Look at Today's Ratings for Medpace(MEDP.US), With a Forecast Between $535 to $692Market news · 24 Jul 2026
  • William Blair Initiates Medpace(MEDP.US) With Hold RatingMarket news · 23 Jul 2026
  • Mizuho Securities Maintains Medpace(MEDP.US) With Buy Rating, Raises Target Price to $586Market news · 13 Jul 2026
  • Jefferies Maintains Medpace(MEDP.US) With Buy Rating, Cuts Target Price to $490Market news · 15 Jun 2026
  • A Quick Look at Today's Ratings for Medpace(MEDP.US), With a Forecast Between $400 to $477Market news · 25 Apr 2026
  • William Blair Maintains Medpace(MEDP.US) With Hold RatingMarket news · 23 Apr 2026

Discussion

No comments yet — be the first to weigh in on MEDP.

Leave a comment

Scroll to Top